Continuous Monitoring Data Ingestion
ICU data ingestion consolidates bedside monitors, ventilators, and infusion devices into a unified time series, giving models the resolution that hourly charted vital signs cannot provide.
Custom Software
AI Critical Care and ICU Software Development
AI critical care software applies machine learning to continuous ICU data streams including vitals, ventilator settings, labs, and nursing assessments to surface early deterioration signals, risk scores, and screening prompts. It functions as decision support only: the intensivist and bedside nurse make every clinical decision.
The ICU produces more continuous data per patient than any other care setting, and most of it is reviewed in fragments. Taction Software builds AI critical care ICU tooling that consolidates those streams into reviewable signals inside existing workflows. Every deployment is engineered for clinician control, alert discipline, and full auditability of how each score was produced.
Tell Us Your Requirements
Our experts are ready to understand your business goals.
Trusted Partners
Trusted by Industry Leaders Worldwide
Recognition
Awards & Recognitions
What Is AI Critical Care and ICU Software
AI critical care ICU software refers to machine learning applied to intensive care data: bedside monitor waveforms, ventilator parameters, infusion pump records, laboratory results, and nursing documentation. Models identify patterns associated with deterioration, infection, delirium, and weaning readiness, then present them as scores or prompts for the care team. These systems never act. They surface information, and the intensivist, nurse, or respiratory therapist decides what follows. This work sits inside our broader healthcare AI practice, where validation, subgroup performance reporting, and regulatory classification are treated as engineering deliverables rather than documentation added at the end.
Early Deterioration Signals
ICU deterioration alerts flag physiologic trajectories associated with instability, surfacing them on the care team dashboard for clinician assessment rather than triggering any automated intervention.
Sepsis Risk Screening
Sepsis prediction models combine vitals, lactate, white count, and antibiotic timing into a screening prompt. The treating team confirms or dismisses each prompt, and clinical judgment governs treatment.
Ventilator Weaning Support
Ventilator weaning tooling organizes compliance, oxygenation, and spontaneous breathing trial data into a readiness summary. The intensivist and respiratory therapist decide on every extubation.
Delirium Screening Prompts
Delirium screening support flags patients whose sedation, mobility, and assessment patterns warrant formal CAM-ICU evaluation, prompting nursing assessment rather than substituting for it.
Decision Support Boundaries
All outputs carry clinical decision support framing. The software does not diagnose, adjust ventilator settings, order medication, or escalate care autonomously in any configuration we build.
Core AI Critical Care Services
Our AI critical care ICU services span data infrastructure, model development, workflow integration, and long-term monitoring. Critical care projects fail more often on data plumbing and alert design than on model accuracy, so we scope device interfacing and notification routing explicitly rather than treating them as implementation detail. Most engagements open with an assessment of monitor connectivity, EHR flowsheet structure, and existing alarm burden, because adding signals to an environment already suffering alarm fatigue makes outcomes worse. Deliverables are structured so intensivists, nursing leadership, IT, and compliance can each review their portion before anything reaches a live unit.
01
Device and Monitor Integration
We build interfaces to bedside monitors, ventilators, and pumps, normalizing waveform data and device output into a consistent stream suitable for model input and audit.
02
EHR and Flowsheet Integration
Integration reads flowsheet, lab, and order data and writes results back into the chart. Our HL7 integration services cover the interface engine layer this depends on.
03
Predictive Model Development
We develop and validate risk prediction models on institutional ICU data, documenting training provenance, holdout evaluation, and performance by patient subgroup before any clinical exposure.
04
Alert Design and Routing
Alert routing work defines thresholds, suppression logic, escalation paths, and acknowledgment tracking, because reducing alarm fatigue matters as much as detection performance in critical care.
05
Clinical Dashboard Development
Unit-level dashboards present risk, acuity, and census together, complementing tooling such as AI patient acuity scoring already used for staffing decisions.
06
Model Monitoring and Revalidation
We instrument drift detection, unit-level performance tracking, and fairness monitoring across demographic and diagnostic subgroups, with defined thresholds and documented rollback triggers.
Benefits of AI Critical Care Software
The benefits of AI critical care ICU software concentrate in earlier visibility, more consistent screening, and better use of data the unit already generates. ICU teams monitor many parameters across many patients, and subtle multi-variable trends are genuinely difficult to track manually during a shift. Structured screening also makes protocol compliance measurable rather than assumed. We publish no efficacy, mortality, or length-of-stay figures, because those depend entirely on your case mix, staffing model, and current baseline, and claiming them would be unsupportable. What we deliver is instrumentation so your team evaluates impact against its own data.
Earlier Visibility Into Trends
Continuous analysis surfaces multi-parameter physiologic trends that are hard to track manually across a full patient assignment, giving clinicians earlier context for assessment.
More Consistent Screening
Systematic sepsis screening and delirium prompts apply the same criteria to every patient every hour, reducing variation that depends on shift workload and individual practice.
Reduced Documentation Burden
Automated capture of device and assessment data into structured fields reduces manual charting, easing nursing documentation load without removing the review step.
Better Capacity Awareness
Risk and acuity data feed unit planning, working alongside AI inpatient census management for bed capacity and throughput decisions made by clinical leadership.
Measurable Protocol Compliance
Structured data makes protocol adherence for weaning trials, sedation interruption, and mobility genuinely measurable, supporting quality review led by your clinical committees.
Stewardship and Quality Support
Infection-related signals support antimicrobial review, complementing AI antibiotic stewardship programs where the stewardship pharmacist and physician retain all prescribing authority.
Our AI Critical Care Process
We run AI critical care ICU projects in gated phases so clinical stakeholders approve direction before engineering cost accumulates. Discovery establishes intended use, data availability, and regulatory classification, because software producing risk scores that influence treatment may carry Software as a Medical Device obligations. Development is iterative with intensivist and nursing review inside each cycle, not deferred to acceptance testing. Deployment is deliberately slow: silent mode first, where outputs are logged but never displayed, then single-unit availability, then wider rollout. This sequencing exists because critical care models behave differently against real institutional populations than against published cohorts.
Discovery and Regulatory Assessment
Discovery defines intended use, evaluates data availability, and assesses whether SaMD classification applies, producing a fixed-scope estimate with documented regulatory pathway.
Data Assessment and Preparation
We evaluate monitor connectivity, flowsheet completeness, and label quality, because data readiness determines feasibility in critical care far more than model architecture selection.
Model Development and Validation
Development proceeds from cross-validation to external validation, reporting sensitivity, specificity, and alert burden by subgroup so limitations are documented rather than averaged into a single figure.
Alert Burden Calibration
We tune thresholds against your historical data to model alert volume before go-live, because a clinically accurate model with unacceptable false positive load will be ignored.
Silent Mode Evaluation
The system runs in silent deployment, logging predictions against actual clinical events so your team measures agreement and identifies failure modes without any patient impact.
Staged Rollout and Governance
Rollout expands unit by unit with performance dashboards, clinical governance review, and continuing post-deployment surveillance for the life of the deployment.
Technology and Compliance
Critical care software handles PHI, continuous device data, and outputs that may influence treatment, so compliance posture is designed in from the first sprint. Taction holds ISO 27001 certification and follows HIPAA-aligned engineering practice. Where a tool produces risk scores intended to guide clinical management, it may meet the definition of Software as a Medical Device, which materially changes validation, documentation, and change control obligations. We assess that during discovery rather than retrofitting later. Technically we build on standards-based interfaces, containerized inference with defined latency budgets, and audit logging detailed enough to reconstruct any individual score.
HIPAA-Aligned Engineering
Builds apply encryption in transit and at rest, role-based access, and full audit logging. Our HIPAA compliance software development practice defines these baseline controls.
SaMD and FDA Considerations
Risk scores guiding management may trigger SaMD classification. Our FDA SaMD compliance services cover design history, validation records, and change control requirements.
Interoperability Standards
We implement HL7 v2, FHIR resources, and device gateway protocols so scores and captured data move between monitoring, EHR, and analytics systems without manual re-entry.
Validation and Bias Monitoring
Validation reports performance by age, sex, race, and admitting diagnosis, with continuing bias monitoring, since critical care models are known to perform unevenly across populations.
Real-Time Infrastructure Requirements
Streaming inference carries latency and availability requirements. We define degradation behavior explicitly, so clinicians always know when a signal is stale or unavailable.
Deployment Security
Deployments run on-premise, in your cloud tenancy, or hybrid, with network segmentation, signed container images, and documented penetration testing before production release.
Why Choose Taction Software
Taction Software was founded in 2013 and has spent over 12 years building healthcare software, delivering more than 200 healthcare projects. We work from four US offices in Chicago, Cheyenne, Austin, and Sacramento, and hold ISO 27001 certification. Our credibility in clinical software comes from delivery rather than positioning: we have built EHR and EMR platforms, FDA-registered mobile applications, and behavioral health systems, so the integration and regulatory constraints that stall critical care projects are familiar ground. Our leadership brings more than 20 years of personal experience in the field, which shapes how we scope regulated clinical work.
01
Established Healthcare Focus
Founded in 2013, we have concentrated on healthcare rather than treating it as one vertical among several, producing practical depth in clinical workflow and hospital systems integration.
02
Regulated Product Experience
We delivered the FDA-registered applications Revive Ease and PainKare, so design controls, validation documentation, and change management are established practice rather than unfamiliar territory.
03
EHR and Clinical Systems Depth
Our Voyant Health EHR and EMR work means EHR integration is handled by engineers who have built systems on both sides of the interface, not only consumed an API.
04
Decision Support Engineering
We build clinical decision support with clinician control designed in, an approach detailed in our clinical decision support software development practice.
05
US-Based Delivery Teams
Four US offices support overlapping working hours, on-site discovery in the unit, and direct engineer access, shortening stakeholder review cycles on regulated builds.
06
Certified Security Posture
ISO 27001 certification and HIPAA-aligned engineering mean security controls are documented and auditable, supporting your vendor risk assessment without a long remediation phase.
Pricing
AI critical care ICU pricing depends on scope, data condition, device integration surface, and regulatory pathway. A single screening model reading existing EHR data costs considerably less than a streaming platform integrating multiple device vendors with external validation and a regulatory submission. We price after discovery, because monitor connectivity and flowsheet quality vary enormously between hospitals and drive a large share of total effort. Discovery produces an itemized, fixed-scope estimate with phase-level breakdown so components can be approved or deferred. Cloud infrastructure, device gateway licensing, and third-party model licensing are separate from engineering cost and itemized clearly.
MVP or Single Module
An MVP covering one screening model, EHR data only, and a single unit typically runs $40,000 to $80,000, suitable for validating clinical value before wider commitment.
Full Platform Build
A full platform with device integration, multiple models, dashboards, alert routing, and monitoring typically falls between $80,000 and $200,000 depending on validation depth required.
Enterprise Deployment
Enterprise engagements covering multi-site rollout, custom model development, external validation, and regulatory documentation start at $200,000 and scale with unit count and submission scope.
Discovery Phase Scoping
Discovery is a paid, time-boxed phase producing an itemized estimate, architecture plan, and regulatory assessment. It is deliberately separable so you can evaluate our work first.
Cost Drivers to Expect
Device integration breadth, external validation requirements, monitor vendor heterogeneity, and SaMD documentation are the largest variables, each identified during discovery for realistic budget planning.
Ongoing Support Costs
Post-launch model monitoring, revalidation cycles, and support are quoted separately as a retainer sized to your unit count and governance cadence.
Get Started
If you are evaluating AI critical care ICU tooling for deterioration screening, sepsis detection, weaning support, or delirium prompts, the fastest next step is a discovery call with our clinical engineering team. We will review your monitor connectivity, EHR data, current alarm burden, and intended use, then return an itemized, fixed-scope estimate with a clear regulatory assessment. Contact us to schedule that conversation.
FAQs
Frequently Asked Questions
Teams evaluating AI critical care ICU software consistently raise three concerns: whether the software acts on patients, what regulatory obligations the intended use creates, and whether new signals will worsen an already heavy alarm burden. The answers below reflect how we scope and deliver these projects in practice. If your situation involves a specialty population, a mixed monitor vendor environment, or an intended use likely to require FDA submission, the specifics matter more than any general answer.
No. Every tool we build functions as clinical decision support. It surfaces scores, prompts, and trends for the care team, and the intensivist, nurse, or respiratory therapist decides what happens next. The software does not adjust ventilator settings, place orders, administer medication, or escalate care autonomously in any configuration.
That risk is real, which is why alert design is a scoped deliverable rather than a configuration afterthought. We model expected alert volume against your historical data before go-live, tune thresholds and suppression logic with your clinical governance group, and track acknowledgment rates after deployment so burden stays visible.
It depends on intended use. Risk scores intended to guide clinical management may meet the definition of Software as a Medical Device and require a regulatory pathway, while internal quality monitoring and research tooling often does not. We assess classification during discovery and build the design controls the applicable pathway requires.
An MVP or single module runs $40,000 to $80,000. A full platform typically falls between $80,000 and $200,000. Enterprise deployments with multi-site rollout and regulatory documentation start at $200,000. Discovery produces an itemized, fixed-scope estimate, with infrastructure and third-party licensing quoted separately from engineering.
Usually yes, through device gateways and vendor-supported interfaces, though capability varies by manufacturer and equipment generation. Some older monitors expose limited or no network data. We verify what your specific fleet supports during discovery rather than assuming a level of access that may not exist.
We evaluate on your held-out institutional data and report sensitivity, specificity, and alert burden by age, sex, race, and admitting diagnosis rather than a single aggregate figure. Subgroup reporting is standard because critical care models are documented to perform unevenly across populations.